OpenAI is in talks to raise up to $40 billion in funding, with SoftBank leading the round with $15-25 billion, potentially valuing the company at $340 billion. The funding may be used for the Stargate joint venture and to compete with other AI giants. DeepSeek, a Chinese startup, is emerging as a competitor to OpenAI with its cost-effective AI model.
Full Article
New non-opioid painkiller approved by US health agency
The US FDA has approved a new non-opioid painkiller, Journavx, by Vertex Pharmaceuticals, which targets pain signals before reaching the brain to provide relief for moderate to severe pain without the addictive potential of opioids. Clinical trials showed effectiveness in reducing post-surgery pain, marking an important milestone in acute pain management amidst the opioid crisis in the US. Priced at $15.50 per capsule, Journavx is the first new class of pain medicine approved in over...
Read more